Cargando…
Eltrombopag Dose Adjustment During Infection-Induced Thrombocytosis in a Patient With Chronic Idiopathic Thrombocytopenic Purpura
Idiopathic thrombocytopenic purpura (ITP) is an immune disorder in which antibodies attack platelets, leading to platelet destruction and increased bleeding risk. Standard treatment is to maintain a platelet count sufficient to mitigate the bleeding risk. First-line therapies include steroids and IV...
Autores principales: | Ahmed, Mohanad, Abdelmahmuod, Elabbass, Ali, Elrazi A, Yassin, Mohamed A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080309/ https://www.ncbi.nlm.nih.gov/pubmed/33936878 http://dx.doi.org/10.7759/cureus.14166 |
Ejemplares similares
-
Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
por: Ahmed, Mohanad, et al.
Publicado: (2020) -
Treatment-Free Remission in Chronic Idiopathic Thrombocytopenic Purpura
por: Ahmed, Mohanad, et al.
Publicado: (2020) -
Low-Dose Eltrombopag in a Patient with Chronic Idiopathic Thrombocytopenic Purpura Post Sleeve Gastrectomy
por: Ahmed, Mohanad A., et al.
Publicado: (2020) -
Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
por: Abdelmahmuod, Elabbass A., et al.
Publicado: (2021) -
Iron Deficiency Anemia-Induced Neutropenia in Adult Female
por: Abdelmahmuod, Elabbass, et al.
Publicado: (2020)